NASDAQ:MENS

Jyong Biotech (MENS) Stock Price, News & Analysis

Jyong Biotech logo
$1.86 +0.06 (+3.33%)
Closing price 11/18/2026 04:00 PM Eastern
Extended Trading
$1.86 +0.00 (+0.27%)
As of 11/18/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Jyong Biotech Stock (NASDAQ:MENS)

Advanced

Key Stats

Today's Range
$1.58
▼
$1.91
50-Day Range
$1.65
▼
$2.38
52-Week Range
$1.43
▼
$38.88
Volume
69,523 shs
Average Volume
39,953 shs
Market Capitalization
$141.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Jyong Biotech is a clinical-stage biopharmaceutical company based in Taiwan that develops treatments for urological diseases. Its research focuses on botanical drug candidates, including therapies for conditions affecting the prostate and urinary system.

The company’s pipeline includes MCS-2, a botanical drug candidate being developed for benign prostatic hyperplasia, a noncancerous enlargement of the prostate. Jyong Biotech is also developing other candidates for urological conditions.

Jyong Biotech was established in Taiwan and conducts drug development activities there. Its focus is on advancing its pipeline through clinical development; its candidates are investigational and are not established treatments.

AI Generated. May Contain Errors.

Receive MENS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Jyong Biotech and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MENS Stock News Headlines

My $247 scanner for $7
Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment that covers a full year, with no subscription and no re-bills. Every night after the close, the scanner screens nearly a thousand of America's biggest stocks. It returns a short list of qualifying setups with the exact buy price next to each one. There's nothing to install. If you decide it's not for you, you get the $7 back and keep the scanner for the year.tc pixel
Jyong Biotech Ltd. Ordinary Shares (MENS)
See More Headlines

MENS Stock Analysis - Frequently Asked Questions

Jyong Biotech's stock was trading at $3.95 at the beginning of 2026. Since then, MENS stock has decreased by 52.9% and is now trading at $1.86.

Jyong Biotech (MENS) raised $21 million in an IPO on Tuesday, June 17th 2025. The company issued 2,666,667 shares at $7.50-$8.50 per share.

Top institutional shareholders of Jyong Biotech include StoneX Group Inc. (0.02%).

Shares of MENS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
11/19/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:MENS
Previous Symbol
NASDAQ:MENS
CIK
1954488
Fax
N/A
Employees
27
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.33) per share
Price / Book
-5.64

Miscellaneous

Outstanding Shares
76,030,000
Free Float
N/A
Market Cap
$141.42 million
Optionable
Optionable
Beta
2.52
The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

This page (NASDAQ:MENS) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners